← back to search

Dee Mangin

McMaster University · CA
Area of research
Epidemiology · Geriatrics and Gerontology
Research interest
Research interests include Medicine, Polypharmacy, Deprescribing, Kidney disease, Cohort, and Medical prescription.
h-index
citations
649
works
13
NIH funding
primary concept
email

Recent publications

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
The Journals of Gerontology Series A 2023cited by 36position: lastdoi
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)
Drugs & Aging 2023cited by 21position: firstdoi
Polypharmacy and medicine regimens in older adults in residential aged care
Archives of Gerontology and Geriatrics 2022cited by 36position: middledoi
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
BMJ Quality & Safety 2022cited by 11position: middledoi
Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study
Drug Safety 2022cited by 3position: middledoi
Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada:A longitudinal cohort study
Research at the University of Copenhagen (University of Copenhagen) 2022cited by 0position: middle
Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis
Systematic Reviews 2021cited by 19position: middledoi
Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study
Kidney International Reports 2019cited by 104position: middledoi
Quality of Chronic Kidney Disease Management in Canadian Primary Care
JAMA Network Open 2019cited by 99position: middledoi
Multimorbidity Frameworks Impact Prevalence and Relationships with Patient‐Important Outcomes
Journal of the American Geriatrics Society 2019cited by 71position: middledoi
The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system
Cochrane Database of Systematic Reviews 2019cited by 2position: middledoi
International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action
Drugs & Aging 2018cited by 238position: firstdoi
A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol
BMJ Open 2017cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Delphine S. Tuot · San Francisco General Hospital4 papers (2017–2021)Navdeep Tangri · Seven Oaks General Hospital4 papers (2017–2021)Barbara Mintzes · The University of Sydney4 papers (2019–2022) · 4 papers (2017–2021) · 4 papers (2019–2022)Allan Grill · Sunnybrook Health Science Centre4 papers (2017–2021)Dorothea Nitsch · London School of Hygiene & Tropical Medicine4 papers (2017–2021) · 4 papers (2019–2022) · 4 papers (2017–2021)Neil Drummond · Queen's University4 papers (2017–2021)Paul E. Ronksley · Universidade Federal de Minas Gerais4 papers (2017–2021)Colin R. Dormuth · McGill University Health Centre3 papers (2022–2022)Anna Kemp · University of Wollongong3 papers (2022–2022)Alexander Singer · Dalhousie University3 papers (2017–2019) · 3 papers (2019–2021) · 3 papers (2022–2022)Patrick C. Souverein · Utrecht University3 papers (2022–2022)Aminu K. Bello · University of Alberta3 papers (2017–2019)Sallie‐Anne Pearson · University of Sydney3 papers (2022–2022) · 3 papers (2022–2022)